12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks experienced significant movements. China SXT Pharmaceuticals (SXTC) saw a substantial increase of 154.2%, while cbdMD (YCBD) rose by 48.12%. Other gainers included Kintara Therapeutics (KTRA), Lineage Cell Therapeutics (LCTX), Connect Biopharma Hldgs (CNTB), and China Pharma Holding (CPHI). Conversely, Microbot Medical (MBOT) led the losers with a 25.9% decline, followed by SenesTech (SNES), Cingulate (CING), Bone Biologics (BBLG), Universe Pharmaceuticals (UPC), and Ocean Biomedical (OCEA).
December 29, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bone Biologics shares fell 13.17% to $5.21 with a market cap of $2.7 million.
The pre-market decline for BBLG could suggest a negative outlook among investors, possibly leading to further short-term depreciation.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Cingulate shares declined by 14.06% to $8.44 with a market cap of $7.9 million.
CING's pre-market drop may indicate bearish investor sentiment, which could negatively impact the stock in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Microbot Medical stock declined by 25.9% to $1.52 with a market cap of $17.7 million.
MBOT's significant pre-market drop suggests negative investor sentiment, which could lead to further short-term declines.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Ocean Biomedical shares fell 9.91% to $0.7 with a market cap of $23.7 million.
OCEA's pre-market decline indicates possible investor concern, which could lead to further short-term price drops.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 90
NEGATIVE IMPACT
SenesTech stock fell 20.81% to $1.37 with a market cap of $1.0 million.
The sharp pre-market decline in SNES could reflect negative market sentiment, potentially leading to further short-term downside.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Universe Pharmaceuticals stock decreased by 10.0% to $1.8 with a market cap of $6.5 million.
UPC's pre-market drop may reflect a bearish trend, which could continue to affect the stock price in the short term.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Connect Biopharma Hldgs stock rose 16.36% to $1.28 with a market cap of $70.4 million.
The pre-market rise for CNTB could signal growing investor confidence, potentially leading to short-term price increases.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 90
POSITIVE IMPACT
China Pharma Holding shares increased by 15.9% to $0.14 with a market cap of $4.6 million.
CPHI's pre-market gain could be a positive signal for investors, possibly leading to further short-term price growth.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 90
POSITIVE IMPACT
Kintara Therapeutics stock rose 29.01% to $0.25 in pre-market trading.
KTRA's notable pre-market increase could attract investor attention and potentially lead to further short-term gains.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Lineage Cell Therapeutics stock moved upwards by 18.26% to $1.36 with a market cap of $237.9 million.
LCTX's pre-market increase could indicate a positive trend, potentially leading to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
China SXT Pharmaceuticals stock surged 154.2% in pre-market trading with a market cap of $2.8 million.
The substantial pre-market gain for SXTC indicates strong investor interest which could lead to continued momentum in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
cbdMD stock increased by 48.12% in pre-market trading with a market cap of $3.4 million.
The significant pre-market rise in YCBD's stock price suggests positive sentiment that could drive short-term price action.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100